Setsuko K. Chambers

7.5k total citations · 1 hit paper
118 papers, 4.2k citations indexed

About

Setsuko K. Chambers is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Molecular Biology. According to data from OpenAlex, Setsuko K. Chambers has authored 118 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Reproductive Medicine, 31 papers in Obstetrics and Gynecology and 29 papers in Molecular Biology. Recurrent topics in Setsuko K. Chambers's work include Ovarian cancer diagnosis and treatment (55 papers), Endometrial and Cervical Cancer Treatments (29 papers) and Reproductive System and Pregnancy (11 papers). Setsuko K. Chambers is often cited by papers focused on Ovarian cancer diagnosis and treatment (55 papers), Endometrial and Cervical Cancer Treatments (29 papers) and Reproductive System and Pregnancy (11 papers). Setsuko K. Chambers collaborates with scholars based in United States, China and Netherlands. Setsuko K. Chambers's co-authors include Joseph T. Chambers, Barry M. Kacinski, Ernest I. Kohorn, Peter E. Schwartz, Ho-Hyung Woo, Peter E. Schwartz, Wenxin Zheng, Maria L. Carcangiu, Yi Zhou and Darryl Carter and has published in prestigious journals such as Journal of Clinical Oncology, Molecular and Cellular Biology and Cancer.

In The Last Decade

Setsuko K. Chambers

116 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

NRF2 controls iron homeostasis and ferroptosis through HERC2 and VAMP8

2023 301 citations Setsuko K. Chambers et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Setsuko K. Chambers United States	42	1.5k	1.4k	1.0k	871	792	118	4.2k
Catherine Lhommé France	33	2.0k 1.3×	1.3k 0.9×	1.0k 1.0×	949 1.1×	498 0.6×	119	4.2k
K. Czerwenka Austria	41	781 0.5×	1.5k 1.0×	1.0k 1.0×	1.3k 1.5×	646 0.8×	179	4.6k
Gilad Ben‐Baruch Israel	39	1.7k 1.1×	1.4k 1.0×	1.3k 1.2×	995 1.1×	657 0.8×	152	4.7k
Patricia Pautier France	33	1.5k 1.0×	1.6k 1.1×	1.1k 1.1×	1.8k 2.1×	600 0.8×	200	4.8k
Claes G. Tropé Norway	36	1.2k 0.8×	1.4k 1.0×	928 0.9×	1.2k 1.4×	787 1.0×	149	3.8k
G. Gitsch Austria	35	762 0.5×	1.1k 0.8×	834 0.8×	1.0k 1.2×	811 1.0×	166	3.7k
Stefania Bellone United States	41	922 0.6×	1.8k 1.2×	990 1.0×	2.4k 2.7×	761 1.0×	155	5.4k
Ingo B. Runnebaum Germany	36	1.1k 0.7×	1.4k 1.0×	885 0.9×	1.7k 1.9×	972 1.2×	183	4.9k
Federica Tomao Italy	38	1.1k 0.7×	1.2k 0.8×	607 0.6×	2.0k 2.3×	731 0.9×	243	4.9k
Carolyn Y. Muller United States	35	880 0.6×	1.2k 0.8×	481 0.5×	972 1.1×	504 0.6×	104	3.4k

Countries citing papers authored by Setsuko K. Chambers

Since Specialization

Citations

This map shows the geographic impact of Setsuko K. Chambers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Setsuko K. Chambers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Setsuko K. Chambers more than expected).

Fields of papers citing papers by Setsuko K. Chambers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Setsuko K. Chambers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Setsuko K. Chambers. The network helps show where Setsuko K. Chambers may publish in the future.

Co-authorship network of co-authors of Setsuko K. Chambers

This figure shows the co-authorship network connecting the top 25 collaborators of Setsuko K. Chambers. A scholar is included among the top collaborators of Setsuko K. Chambers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Setsuko K. Chambers. Setsuko K. Chambers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vulsteke, Christof, Setsuko K. Chambers, M.J. Rubio Pérez, et al.. (2024). Tolerability of the niraparib individualized starting dose in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy. European Journal of Cancer. 208. 114157–114157. 3 indexed citations

Tanyi, János L., Leslie M. Randall, Setsuko K. Chambers, et al.. (2023). A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor–Positive Ovarian Cancer (Study 006). Obstetrical & Gynecological Survey. 78(6). 341–342.

Woo, Ho-Hyung & Setsuko K. Chambers. (2021). Regulation of closely juxtaposed proto-oncogene c-fms and HMGXB3 gene expression by mRNA 3′ end polymorphism in breast cancer cells. RNA. 27(9). 1068–1081. 3 indexed citations

Pandey, Ritu, et al.. (2019). Circulating miRNA Profiling of Women at High Risk for Ovarian Cancer. Translational Oncology. 12(5). 714–725. 13 indexed citations

Chen, Hao, et al.. (2017). Tubal Cytology of the Fallopian Tube as a Promising Tool for Ovarian Cancer Early Detection. Journal of Visualized Experiments. 8 indexed citations

Sinharay, Sanhita, Edward A. Randtke, Kyle M. Jones, et al.. (2016). Noninvasive detection of enzyme activity in tumor models of human ovarian cancer using catalyCEST MRI. Magnetic Resonance in Medicine. 77(5). 2005–2014. 34 indexed citations

Li, Jie, Yan Ning, Nisreen Abu Shahin, et al.. (2013). Secretory cell expansion with aging: Risk for pelvic serous carcinogenesis. Gynecologic Oncology. 131(3). 555–560. 23 indexed citations

Chambers, Setsuko K.. (2009). Role of CSF-1 in Progression of Epithelial Ovarian Cancer. Future Oncology. 5(9). 1429–1440. 43 indexed citations

Zheng, Wenxin, Sharon X. Liang, Xiaofang Yi, et al.. (2006). Occurrence of Endometrial Glandular Dysplasia Precedes Uterine Papillary Serous Carcinoma. International Journal of Gynecological Pathology. 26(1). 38–52. 30 indexed citations

10.

Turner, Bruce, Jonathan Knisely, Barry M. Kacinski, et al.. (1998). Effective Treatment of Stage I Uterine Papillary Serous Carcinoma with High Dose-Rate Vaginal Apex Radiation (192Ir) and Chemotherapy. International Journal of Radiation Oncology*Biology*Physics. 40(1). 77–84. 64 indexed citations

11.

Price, Fredric V., Setsuko K. Chambers, Maria Luisa Carcangiu, et al.. (1998). CA 125 may not reflect disease status in patients with uterine serous carcinoma. Cancer. 82(9). 1720–1725. 33 indexed citations

12.

Chambers, Setsuko K., et al.. (1997). Expression of plasminogen activator inhibitor-2 in epithelial ovarian cancer: A favorable prognostic factor related to the actions of CSF-1. International Journal of Cancer. 74(6). 571–575. 22 indexed citations

13.

Chambers, Setsuko K., et al.. (1997). Expression of plasminogen activator inhibitor‐2 in epithelial ovarian cancer: A favorable prognostic factor related to the actions of CSF‐1. International Journal of Cancer. 74(6). 571–575. 4 indexed citations

14.

Chambers, Setsuko K., Carol A. Davis, Peter E. Schwartz, Ernest I. Kohorn, & Joseph T. Chambers. (1996). Modulation of platinum sensitivity and resistance by cyclosporin A in refractory ovarian and fallopian tube cancer patients: a phase II study.. PubMed. 2(10). 1693–7. 8 indexed citations

15.

Fishman, David A., Kenneth B. Roberts, Joseph T. Chambers, et al.. (1996). Radiation Therapy as Exclusive Treatment for Medically Inoperable Patients with Stage I and II Endometrioid Carcinoma of the Endometrium. Gynecologic Oncology. 61(2). 189–196. 52 indexed citations

16.

Chambers, Setsuko K., et al.. (1994). Post-transcriptional regulation of c-fms proto-oncogene expression by dexamethasone and of CSF-1 in human breast carcinomas in vitro. Steroids. 59(9). 514–522. 18 indexed citations

17.

Price, Fredric V., Setsuko K. Chambers, Maria Luisa Carcangiu, et al.. (1993). Intravenous Cisplatin, Doxorubicin, and Cyclophosphamide in the Treatment of Uterine Papillary Serous Carcinoma (UPSC). Gynecologic Oncology. 51(3). 383–389. 61 indexed citations

18.

Kacinski, Barry M., et al.. (1992). NEU protein overexpression in benign, borderline, and malignant ovarian neoplasms. Gynecologic Oncology. 44(3). 245–253. 54 indexed citations

19.

Mayer, Allan R., Setsuko K. Chambers, Carole Holm, et al.. (1992). Ovarian cancer staging: Does it require a gynecologic oncologist?. Gynecologic Oncology. 47(2). 223–227. 103 indexed citations

20.

Chambers, Setsuko K., Joseph T. Chambers, Carole Holm, Richard E. Peschel, & Peter E. Schwartz. (1990). Sequelae of lateral ovarian transposition in unirradiated cervical cancer patients. Gynecologic Oncology. 39(2). 155–159. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact